[New therapeutic approaches in diabetes]

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Diabetes & metabolism·2019

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.

Diabetes & metabolism·2018

After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?

Diabetes & metabolism·2017

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues.

Diabetes research and clinical practice·2016

Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.

Diabetes & metabolism·2014

Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.

Diabetes, obesity & metabolism·2014

Decision-making in primary hyperparathyroidism in older patients: surgical or conservative management?

Annales d'endocrinologie·2026

Rebuilding Beta-Cell Function: Advances In Replacement, Preservation And Regeneration.

Annales d'endocrinologie·2026

Screening and Management of Menstrual Cycle Disorders in Women Athletes by Sports Physicians: The HYPOFIT Study.

Annales d'endocrinologie·2026

Diabetes in deprived patients.

Annales d'endocrinologie·2026

Determinants of Glycemic Control with Automated Insulin Delivery in adults living with type 1 diabetes: A 12-Month Sub-Analysis of the French OB2F Registry.

Annales d'endocrinologie·2026

The tip of the iceberg: morbidity in polycystic ovary syndrome in reproductive-age women.

Annales d'endocrinologie·2026

PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.

Neuro-oncology·2026

Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care.

The Journal of clinical endocrinology and metabolism·2026

Advances in Formulation and Technological Strategies for Montelukast Pulmonary Delivery.

ACS omega·2026

Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy.

ACS omega·2026

Exosomes in brain diseases: Mechanisms, advances, and perspectives.

Bioactive materials·2026

Quantification of Ocular Gene Therapy-Related Inflammation Using the VRMACS Grading System.

Ophthalmology science·2026

Related Experiment Videos

[New therapeutic approaches in diabetes]

Related Concept Videos

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.

After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues.

Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.

Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.

Decision-making in primary hyperparathyroidism in older patients: surgical or conservative management?

Rebuilding Beta-Cell Function: Advances In Replacement, Preservation And Regeneration.

Screening and Management of Menstrual Cycle Disorders in Women Athletes by Sports Physicians: The HYPOFIT Study.

Diabetes in deprived patients.

Determinants of Glycemic Control with Automated Insulin Delivery in adults living with type 1 diabetes: A 12-Month Sub-Analysis of the French OB2F Registry.

The tip of the iceberg: morbidity in polycystic ovary syndrome in reproductive-age women.

PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.

Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care.

Advances in Formulation and Technological Strategies for Montelukast Pulmonary Delivery.

Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy.

Exosomes in brain diseases: Mechanisms, advances, and perspectives.

Quantification of Ocular Gene Therapy-Related Inflammation Using the VRMACS Grading System.

Related Experiment Videos

[New therapeutic approaches in diabetes]

Related Concept Videos

Related Articles